company logo
Protein therapeutics market
Protein therapeutics market
DUBLIN, Oct. 8, 2024 (Globe Newswire) — The “Protein Therapeutics – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.
The global market for protein therapeutics is estimated at USD 364 billion in 2023 and is projected to reach USD 541.2 billion by 2030, growing at a CAGR of 5.8% from 2023 to 2030. This comprehensive report provides a detailed analysis of market trends. Provide drivers and forecasts to help you make informed business decisions.
Protein therapeutics are emerging as a cornerstone of modern medicine, providing targeted and effective treatments for a wide range of diseases, including cancer, autoimmune diseases, and genetic disorders. Unlike traditional small molecule drugs, protein therapeutics such as monoclonal antibodies, cytokines, and recombinant proteins are designed to interact with specific biological targets, resulting in highly precise therapeutic effects. is obtained.
How are technological innovations shaping the protein therapeutics market?
Technological innovations have significantly advanced the field of protein therapeutics, increasing the efficiency, specificity, and scalability of these treatments. The advent of recombinant DNA technology and monoclonal antibody production has revolutionized the development of protein-based drugs, allowing for the mass production of highly pure and consistent biologics. Innovations in protein engineering, such as the development of bispecific antibodies and antibody-drug conjugates, have further expanded the therapeutic potential of proteins by combining multiple mechanisms of action into a single therapy.
Additionally, advances in drug delivery systems such as nanoparticles and sustained-release formulations have improved the stability and bioavailability of protein therapeutics, making them more effective and convenient for patients. These technological advances are facilitating the adoption of protein therapeutics in clinical practice.
What are the new applications of protein therapy?
Emerging applications for protein therapeutics are expanding their role in medicine beyond traditional indications. In oncology, protein therapeutics are used to develop new immunotherapies, such as checkpoint inhibitors and CAR-T cell therapy, which harness the body’s immune system to fight cancer.
The rise of personalized medicine has also facilitated the use of protein therapeutics in the development of targeted therapies tailored to the genetic and molecular profile of individual patients. In the field of regenerative medicine, growth factors and other protein-based therapies are being investigated to promote tissue repair and regeneration in diseases such as heart disease and neurodegenerative diseases. These new applications are expanding the scope of protein therapeutics and making them important components of future medicine.
What are the main growth drivers of the market?
The growth of the protein therapeutics market is driven by several factors. This is largely due to the increasing prevalence of chronic diseases such as cancer and autoimmune diseases, which often require targeted and effective treatment with protein therapeutics. Technological advances in protein engineering, recombinant DNA technology, and drug delivery systems have greatly improved the development and administration of protein-based drugs and facilitated their adoption in clinical practice.
story continues
The rise of personalized medicine has also increased the demand for protein therapeutics, as they can be tailored to the specific needs of individual patients. Furthermore, increasing focus on biologics in pharmaceutical research and expanding applications in areas such as oncology and regenerative medicine are further driving the market. As the global healthcare landscape continues to evolve, the demand for protein therapeutics is expected to increase significantly.
Why you should buy this report:
Detailed Market Analysis: Access a thorough analysis of the global Protein Therapeutics Market covering all major geographic regions and market segments.
Competitive Insights: Get an overview of the competitive landscape, including market presence of key players across different geographies.
Future trends and drivers: Understand the key trends and drivers shaping the future of the global Protein Therapeutics market.
Actionable Insights: Benefit from actionable insights that help you identify new revenue opportunities and make strategic business decisions.
Key insights:
Market Growth: Understand the significant growth trajectory of the monoclonal antibody segment expected to reach USD 284.7 billion by 2030 at a CAGR of 6.4%. The insulin segment is also expected to grow at a CAGR of 5.8% during the analysis period.
Regional analysis: Gain insight into the US market, estimated to be $98.3 billion in 2023, and the Chinese market, expected to grow at a phenomenal CAGR of 5.4% and reach $84.1 billion by 2030. You can. You can see growth trends in other major regions such as Japan, Canada, and Germany. , and Asia Pacific.
Report features:
Comprehensive market data: Independent analysis of annual sales and market forecasts in million USD from 2023 to 2030.
Detailed regional analysis: Detailed insights into key markets including the US, China, Japan, Canada, Europe, Asia Pacific, Latin America, Middle East and Africa.
Company Overview: Covers major companies such as Abbott Laboratories, Amgen, Inc., and AstraZeneca PLC.
Free Updates: Receive 1 year of free report updates to stay on top of the latest market trends.
Key attributes:
report attributes
detail
Number of pages
181
Forecast period
2023-2030
Estimated market value in 2023 (USD)
$364 billion
Projected market value to 2030 (USD)
$541.2 billion
compound annual growth rate
5.8%
Target area
global
Main topics covered:
Market overview
Insights into the influencer market
Global market trajectory
Protein Therapeutics – Global Major Competitors Market Share Percentage in 2024 (E)
Competitive Market Presence – Strong/Active/Niche/Mediocre (E) for Players Worldwide in 2024
Latest information on the world economy
Market trends and drivers
Rising prevalence of chronic diseases drives market growth
Increased use in targeted and personalized medicine expands addressable market opportunity
Technological advances in protein engineering strengthen market position
Increasing focus on biopharmaceuticals drives adoption of protein therapeutics
Rapid increase in demand for monoclonal antibodies creates new opportunities
Biosimilar and biobetter development sustains market growth
Expanding applications in oncology and autoimmune diseases highlight market potential
Rapid demand for protein therapeutics in rare diseases expands market horizons
Increasing awareness of the benefits of protein-based medicines drives market adoption
Innovation in drug delivery systems creates new market opportunities
Increasing demand for cost-effective and scalable therapeutics draws attention to market trends
Focus on carefully selected players (16 players in total)
Abbott Laboratories
amgen company
AstraZeneca PLC
Baxter International Co., Ltd.
Biogen Co., Ltd.
Boehringer Ingelheim International GmbH
Chugai Pharmaceutical Co., Ltd.
Diasome Pharmaceuticals Co., Ltd.
Eli Lilly and Company
F. Hoffman La Roche AG
Genentech Co., Ltd.
Generex Biotechnology Co., Ltd.
Gene Science Pharma Co., Ltd.
Hualan Biotechnology Co., Ltd.
johnson & johnson
Kyowa Hakko Kirin Co., Ltd.
Merck Serono SA
Novo Nordisk A/S
Oramed Pharmaceuticals Co., Ltd.
Sando International GmbH
Teva Pharmaceutical Industries Ltd.
For more information on this report, please visit https://www.researchandmarkets.com/r/oyraqi.
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source of international market research reports and market data. We provide the latest data on international and regional markets, key industries, top companies, new products and latest trends.
attachment
Contact: Contact: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com EST Call 1-917-300-0470 for office hours. In the US/Canada, call toll-free 1-800-526-8630. GMT For office hours + call 353-1-416-8900
Source link
